Equities
Health CareMedical Equipment and Services
  • Price (USD)224.00
  • Today's Change-1.45 / -0.64%
  • Shares traded1.68m
  • 1 Year change-5.41%
  • Beta0.4248
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Becton Dickinson and Co grew revenues 4.16% from 19.37bn to 20.18bn while net income improved 16.31% from 1.48bn to 1.73bn.
Gross margin45.36%
Net profit margin8.56%
Operating margin12.02%
Return on assets3.14%
Return on equity6.68%
Return on investment3.66%
More ▼

Cash flow in USDView more

In 2024, Becton Dickinson and Co increased its cash reserves by 25.32%, or 375.00m. The company earned 3.80bn from its operations for a Cash Flow Margin of 18.82%. In addition the company generated 2.09bn cash from financing while 5.51bn was spent on investing.
Cash flow per share13.81
Price/Cash flow per share16.24
Book value per share89.64
Tangible book value per share-39.69
More ▼

Balance sheet in USDView more

Becton Dickinson and Co has a Debt to Total Capital ratio of 43.70%, a lower figure than the previous year's 57.13%.
Current ratio1.17
Quick ratio0.7405
Total debt/total equity0.7761
Total debt/total capital0.437
More ▼

Growth rates in USD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 4.40% and 16.36%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.46%
Div growth rate (5 year)4.29%
Payout ratio (TTM)47.80%
EPS growth(5 years)9.57
EPS (TTM) vs
TTM 1 year ago
16.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.